| Analysis | Metabolite Name | Measured Value | Units | Group | Treatment | Sample Source |
|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.2 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.2 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.3 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.3 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.4 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.4 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.5 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.6 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.6 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.7 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.8 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.9 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 1.9 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 2 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 2.1 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 2.2 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 2.2 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 2.3 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 2.5 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 2.5 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 2.6 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 3.4 | uL(plasma), pmole/mg (muscle) | batch2 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 4.6 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 5.4 | uL(plasma), pmole/mg (muscle) | batch1 | Control | muscle |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 7.92 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 9.16 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 9.75 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 10.1 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 10.5 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 11.6 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 12.2 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 12.9 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 13.2 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 13.3 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 13.4 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 14 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 15.35 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 15.6 | uL(plasma), pmole/mg (muscle) | batch2 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 15.7 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 16.7 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 17 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 17.6 | uL(plasma), pmole/mg (muscle) | batch1 | BST204 | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 19.1 | uL(plasma), pmole/mg (muscle) | batch2 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 19.95 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 21.1 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 21.2 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 25.6 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 27.8 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 30.2 | uL(plasma), pmole/mg (muscle) | batch1 | 5FU | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 30.6 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 32.1 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 32.6 | uL(plasma), pmole/mg (muscle) | batch1 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 34.4 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
| Reversed phase POSITIVE ION MODE | L-Tyrosine | 41.2 | uL(plasma), pmole/mg (muscle) | batch2 | Control | plasma |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|